Likewise, IBD has been associated with autoantibody responses against Glycoprotein 2 (GP2) (100, 101), a receptor for bacterial adhesin FimH that is upregulated in the gut epithelium of patients (100). Here, GP2 is linked to inflammatory bowel disease.